Skip to main content
Natera

Medical Director, Oncology (Genitourinary Focus)

RemoteUnited States only
Published
Experience
Senior
Employment
Full-time
$243.8k–$304.7k/yr
Check eligibility

Open to US only. Set where you work from to check your eligibility.

No BS summary

Medical Director for US-remote GU oncology work, aimed at an M.D. with Radiation Oncology residency and 3+ years post-residency GU cancer clinical experience. Needs clinical trial experience, deep GU oncology knowledge, and willingness to travel 40%.

Optional skills

ctDNAMRDLiquid biopsy technologies

What you'll do

  • Partner with the Senior Medical Director, Genitourinary Oncology to develop and execute clinical strategies supporting Natera’s molecular diagnostic tools for GU cancers, including minimal residual disease (MRD) and ctDNA-based monitoring.
  • Lead the design and implementation of clinical studies and treatment protocols that integrate Natera’s technology into standard GU oncology care.
  • Recruit and engage leading principal investigators (PIs) and clinical sites in GU oncology to participate in company-sponsored studies; manage study timelines and budgets in collaboration with Clinical Trial Operations.
  • Advise on product development for the GU oncology portfolio, identifying clinical unmet needs, new product opportunities, key product features, intended use, test report content, and minimum validation requirements.
  • Provide post-launch medical affairs support, including interpretation of test results, clinical consultation for healthcare providers, and guidance on patient counseling (pre- and post-test).
  • Serve as GU oncology expert for support of high-value engagement and events identified by Strategic Accounts, Area Sales and Marketing leaders, commercial or clinical leadership.
  • Lead medical education initiatives, including external training, launch planning, and the creation of scientific and clinical materials specific to GU malignancies.
  • Identify and recruit Key Opinion Leaders (KOLs) in GU oncology to serve on advisory boards and contribute to strategic planning.
  • Support the publication strategy by collaborating with Scientific Communications on manuscripts, abstracts, and conference presentations in GU oncology.
  • Contribute to regulatory strategy by providing medical input into submissions related to GU cancer diagnostic products.
  • Represent Natera’s medical voice externally through public relations, industry panels, advisory boards, and medical conferences, with a focus on GU oncology.

What they require

  • M.D. required (board-certified or board-eligible in Radiation Oncology preferred)
  • Residency training in Radiation Oncology
  • At least 3 years of post-residency clinical experience in GU cancers (prostate, bladder, kidney, etc.) as a primary treating radiation oncologist
  • Deep knowledge of treatment paradigms, clinical guidelines, and diagnostic workflows in GU cancers
  • Minimum 3 years of clinical trial experience in academic, biotech, or pharmaceutical settings
  • Willingness to travel 40% (primarily U.S.-based, with occasional international travel)
  • Expertise in clinical trial design, regulatory/compliance frameworks, and biostatistics
  • Strong understanding of evolving treatment landscapes in GU cancers (including targeted therapies, immunotherapy, and biomarker-driven approaches)
  • Excellent analytical skills and scientific communication ability across varied audiences
  • Quick learner with the ability to critically assess Natera’s technology and competing platforms
  • Strong project management skills; comfortable balancing multiple complex initiatives
  • Proven ability to lead and collaborate across cross-functional teams
  • Skilled communicator, persuasive in scientific discussions and presentations
  • Patient-focused and passionate about improving outcomes in GU cancers
  • Capable of navigating complex systems and influencing without direct authority
  • Preferred: Board-certified or board-eligible in Radiation Oncology
  • Preferred: Experience with ctDNA, MRD, or liquid biopsy technologies
  • Preferred: Established relationships with GU oncology KOLs and academic networks
  • Preferred: Experience supporting product launches or diagnostic adoption in oncology

Benefits

  • Annual performance incentive bonus
  • Long-term equity awards
  • Comprehensive health benefits (medical, dental, vision)
  • 401(k) with company match
  • Generous paid time off and company holidays
  • Additional wellness and work-life benefits
  • Competitive Benefits - Employee benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents.
  • Natera employees and their immediate families receive free testing in addition to fertility care benefits.
  • Pregnancy and baby bonding leave
  • 401k benefits
  • Commuter benefits
  • Generous employee referral program

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Its aim is to make personalized genetic testing and diagnostics part of the standard of care.

🇺🇸 United StatesHealthcareEnterprisenatera.com

What people say about this company

2.7/ 5

Details

Apply routeGreenhouse
$243.8k–$304.7k/yr